HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

"Many" REACH Dossiers Had Quality Problems In 2010, Says ECHA

This article was originally published in The Rose Sheet

Executive Summary

"Many" of the REACH dossiers evaluated by the European Chemicals Agency in 2010 had "at least some quality problems," but they should not be considered representative of all submissions received by the Nov. 30, 2010 deadline, ECHA says.

You may also be interested in...



ECHA, Trade Unions Collaborate To Push REACH Compliance

Fearing that many small and medium-sized personal-care companies will face fines or production stoppages for not being REACH-compliant, the European Chemicals Agency and two union trade associations are working to raise awareness of the 2013 deadline and firms’ responsibilities under Europe’s chemicals registration program.

Quality Concerns Plague REACH Dossiers In 2011, Says ECHA

The European Chemicals Agency issues its latest report detailing problems it has encountered in dossiers submitted under REACH, which overall have been insufficient, it says.

EU Chemicals Agency Leverages 2010 Lessons To Ready Firms For REACH 2013

With the passing of the first registration deadline under Europe’s REACH program and the evaluation of registered dossiers underway, the European Chemicals Agency is working to motivate and support companies subject to the next deadline.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel